Primary care management of allergic rhinitis: a cross-sectional study in four ASEAN countries.

IF 2.3 Multidisciplinary Respiratory Medicine Pub Date : 2020-12-11 eCollection Date: 2020-01-28 DOI:10.4081/mrm.2020.726
Baharudin Abdullah, Kornkiat Snidvongs, Marysia Recto, Niken Lestari Poerbonegoro, De Yun Wang
{"title":"Primary care management of allergic rhinitis: a cross-sectional study in four ASEAN countries.","authors":"Baharudin Abdullah,&nbsp;Kornkiat Snidvongs,&nbsp;Marysia Recto,&nbsp;Niken Lestari Poerbonegoro,&nbsp;De Yun Wang","doi":"10.4081/mrm.2020.726","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In primary care, general practitioners (GPs) and pharmacists are tasked with the frontline responsibility of identifying and managing allergic rhinitis (AR) patients. There are currently no consolidated data on current treatment practices, patient compliance, and usage of guidelines within Southeast Asian Nations (ASEAN). Objective: To assess the attitudes and practices on AR of GPs and pharmacists in 4 ASEAN countries (Philippines, Indonesia, Thailand, and Malaysia).</p><p><strong>Methods: </strong>A cross-sectional survey of 329 GPs and 548 pharmacists was conducted from May to November 2019. Participants answered a questionnaire focused on their i) current practice in the management of AR, ii) views on patient compliance, iii) understanding and usage of guidelines.</p><p><strong>Results: </strong>Clinical history was the most preferred method to diagnose AR by 95.4% of GPs and 58.8% of pharmacists. Second-generation antihistamines were the most widely available treatment option in GP clinics and pharmacies (94.8% and 97.2%) and correspondingly the most preferred treatment for both mild (90.3%, 76.8%) to moderatesevere rhinitis (90.3%, 78.6%) by GPs and pharmacists, respectively. Loratadine was ranked as the most preferred 2<sup>nd</sup> generation antihistamines (GP vs pharmacists: 55.3% vs 58.9%). More than 90% of GPs and pharmacists ranked length and efficacy of treatment as important factors that increase patient compliance. Awareness of the ARIA guidelines was high among GPs (80%) and lower among pharmacists (48.4%). However, only 63.3% of GPs and 48.2% of pharmacists knew how to identify AR patients.</p><p><strong>Conclusions: </strong>The survey in the 4 ASEAN countries has identified a need to strengthen the awareness and use of ARIA guidelines among the primary care practitioners. Adherence to ARIA guidelines, choosing the appropriate treatment option and prioritizing factors that increases patient compliance may contribute to better management outcomes of AR at the primary care practice.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2020-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4c/3a/mrm-15-1-726.PMC7750812.pdf","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multidisciplinary Respiratory Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4081/mrm.2020.726","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/28 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

Background: In primary care, general practitioners (GPs) and pharmacists are tasked with the frontline responsibility of identifying and managing allergic rhinitis (AR) patients. There are currently no consolidated data on current treatment practices, patient compliance, and usage of guidelines within Southeast Asian Nations (ASEAN). Objective: To assess the attitudes and practices on AR of GPs and pharmacists in 4 ASEAN countries (Philippines, Indonesia, Thailand, and Malaysia).

Methods: A cross-sectional survey of 329 GPs and 548 pharmacists was conducted from May to November 2019. Participants answered a questionnaire focused on their i) current practice in the management of AR, ii) views on patient compliance, iii) understanding and usage of guidelines.

Results: Clinical history was the most preferred method to diagnose AR by 95.4% of GPs and 58.8% of pharmacists. Second-generation antihistamines were the most widely available treatment option in GP clinics and pharmacies (94.8% and 97.2%) and correspondingly the most preferred treatment for both mild (90.3%, 76.8%) to moderatesevere rhinitis (90.3%, 78.6%) by GPs and pharmacists, respectively. Loratadine was ranked as the most preferred 2nd generation antihistamines (GP vs pharmacists: 55.3% vs 58.9%). More than 90% of GPs and pharmacists ranked length and efficacy of treatment as important factors that increase patient compliance. Awareness of the ARIA guidelines was high among GPs (80%) and lower among pharmacists (48.4%). However, only 63.3% of GPs and 48.2% of pharmacists knew how to identify AR patients.

Conclusions: The survey in the 4 ASEAN countries has identified a need to strengthen the awareness and use of ARIA guidelines among the primary care practitioners. Adherence to ARIA guidelines, choosing the appropriate treatment option and prioritizing factors that increases patient compliance may contribute to better management outcomes of AR at the primary care practice.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
过敏性鼻炎的初级保健管理:四个东盟国家的横断面研究。
背景:在初级保健中,全科医生(gp)和药剂师肩负着识别和管理过敏性鼻炎(AR)患者的一线责任。目前尚无关于东南亚国家(东盟)当前治疗实践、患者依从性和指南使用情况的综合数据。目的:了解4个东盟国家(菲律宾、印度尼西亚、泰国和马来西亚)全科医生和药师对急性呼吸道感染的态度和做法。方法:2019年5 - 11月对329名全科医生和548名药师进行横断面调查。参与者回答了一份调查问卷,重点是他们i) AR管理的当前实践,ii)对患者依从性的看法,iii)对指南的理解和使用。结果:95.4%的全科医生和58.8%的药师首选临床病史诊断AR。第二代抗组胺药是全科医生诊所和药房最广泛使用的治疗方案(94.8%和97.2%),相应地,全科医生和药剂师对轻度(90.3%,76.8%)至中重度鼻炎(90.3%,78.6%)的首选治疗方案。第二代抗组胺药首选为氯雷他定(GP vs药师:55.3% vs 58.9%)。超过90%的全科医生和药剂师将治疗时间和疗效列为提高患者依从性的重要因素。全科医生(80%)对ARIA指南的认知度较高,而药剂师(48.4%)的认知度较低。然而,只有63.3%的全科医生和48.2%的药剂师知道如何识别AR患者。结论:在4个东盟国家的调查已经确定需要加强认识和使用ARIA指南的初级保健从业人员。坚持ARIA指南,选择适当的治疗方案和优先考虑提高患者依从性的因素可能有助于在初级保健实践中更好地管理AR结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Multidisciplinary Respiratory Medicine
Multidisciplinary Respiratory Medicine Medicine-Pulmonary and Respiratory Medicine
自引率
0.00%
发文量
23
期刊介绍: Multidisciplinary Respiratory Medicine is the official journal of the Italian Respiratory Society - Società Italiana di Pneumologia (IRS/SIP). The journal publishes on all aspects of respiratory medicine and related fields, with a particular focus on interdisciplinary and translational research. The interdisciplinary nature of the journal provides a unique opportunity for researchers, clinicians and healthcare professionals across specialties to collaborate and exchange information. The journal provides a high visibility platform for the publication and dissemination of top quality original scientific articles, reviews and important position papers documenting clinical and experimental advances.
期刊最新文献
Characteristics of culture-negative subclinical pulmonary tuberculosis: a single-center observation. Effective treatment with oral Salbutamol on late onset respiratory impairment in a DOK7 Congenital Myasthenia Syndrome: a case report. Gas exchange abnormalities in Long COVID are driven by the alteration of the vascular component Usability of inhaler devices: a parameter currently misused Characteristics of inpatients with atopic asthma in a tertiary center: do age and gender have an influence?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1